Quarterly Activities Report and 4C Quarterly Cash Flow Report
PAT-DX1 GMP specification testing update
Patrys FY24 Annual Report
PAT-DX1 GMP manufacturing run update
Quarterly Activities Report and 4C Quarterly Cash Flow Report – quarter ended 30 June 2024
Update on GMP manufacturing run of PAT-DX1
Quarterly Activities Report and 4C Quarterly Cash Flow Report – quarter ended 31 March 2024
Positive preclinical data for deoxymabs in vasculitis
Potential to use Deoxymabs to treat autoimmune diseases
Quarterly Activities Report and 4C | 31 December 2023
1
2
3
4
…
6
Next